Skip to content
Menu

Medicenna Therapeutics Corp. MDNA.TO

Full chart Compare
Set alert

Price alert · MDNA.TO

All alert types
0.37 CAD -0.02 (-5.19%)

As ofNov 16, 2026, 3:58 PM EST

0.36 Day range 0.415
0.335 52-week range 1.78
YTD
-60.33%
1 year
-74.30%
Market cap
33.69M
EPS (ttm)
-0.22
Shares out
78.16M
Forward P/E
-8.00
YTD return
-60.33%
1-year return
-74.30%
50-day average
1.96
Volume
17.85K
Avg volume
49.09K
Open
0.415
Previous close
0.385
Day's range
0.36 – 0.415
52-week range
0.335 – 1.78
Beta
1.19

 

No chart data for this range yet.

Key statistics

200-day average
2.03
Enterprise value
75.73M
Price / book
24.53
Free cash flow
-30.38K
Total cash
35.63M
Return on equity
-105.43%
Short % of float
0.15%

About Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on MDNA.TO — it syncs with the Stock Master app.

Institution ownership

MDNA.TO institution ownership
Holder% heldSharesValueReported
Org Partners LLC 0.16%125,000230.00KSep 29, 2024

Fund ownership

MDNA.TO fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.05%34,14462.82KOct 30, 2023